Product
Linperlisib and Chidamide
1 clinical trial
1 indication
Indication
Peripheral T-cell LymphomaClinical trial
PI3Kδ Inhibitor Linperlisib Combined With HDAC Inhibitor Chidamide Versus CHOP in Patients With Peripheral T-cell Lymphoma: a Multicenter, Open Label, Phase Ib/II StudyStatus: Recruiting, Estimated PCD: 2025-12-31